Qube Research & Technologies LTD Charles River Laboratories International, Inc. Transaction History

Qube Research & Technologies LTD

$65.7 Billion
Q3 2024

A detailed history of Qube Research & Technologies LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 18,938 shares of CRL stock, worth $3.81 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

18,938

Previous 70,989 73.32%

Holding current value

$3.81 Million

Previous $14.7 Million 74.56%

% of portfolio

0.01%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $9.78 Million - $12.8 Million	-52,051 Reduced 73.32%	18,938 $3.73 Million
Q2 2024 Aug 14, 2024	BUY	$206.39 - $268.73 $13.5 Million - $17.6 Million	65,649 Added 1229.38%	70,989 $14.7 Million
Q1 2024 May 14, 2024	SELL	$203.52 - $273.43 $24,015 - $32,264	-118 Reduced 2.16%	5,340 $1.45 Million
Q4 2023 Feb 13, 2024	BUY	$164.52 - $238.84 $624,024 - $905,920	3,793 Added 227.81%	5,458 $1.29 Million
Q3 2023 Nov 13, 2023	BUY	$194.44 - $217.61 $323,742 - $362,320	1,665 New	1,665 $326,000
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $3.09 Million - $4.18 Million	16,091 Added 175.93%	25,237 $5.09 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $1.8 Million - $2.29 Million	9,146 New	9,146 $1.99 Million
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $1.92 Million - $2.84 Million	9,388 Added 12.74%	83,092 $17.8 Million
Q1 2022 May 09, 2022	BUY	$255.51 - $362.11 $8.04 Million - $11.4 Million	31,447 Added 74.42%	73,704 $20.9 Million
Q4 2021 Feb 01, 2022	BUY	$351.38 - $448.68 $14.8 Million - $19 Million	42,257 New	42,257 $15.9 Million
Q2 2021 Aug 13, 2021	SELL	$294.17 - $371.65 $3.74 Million - $4.72 Million	-12,707 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $3.54 Million - $4.25 Million	-14,185 Reduced 52.75%	12,707 $3.68 Million
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $724,608 - $824,551	3,264 Added 13.81%	26,892 $6.72 Million
Q3 2020 Nov 12, 2020	SELL	$175.56 - $226.45 $6.26 Million - $8.07 Million	-35,641 Reduced 60.13%	23,628 $5.35 Million
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $7.04 Million - $11.2 Million	59,269 New	59,269 $10.3 Million
Q3 2019 Nov 13, 2019	SELL	$125.07 - $143.67 $280,406 - $322,108	-2,242 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$123.4 - $148.55 $276,662 - $333,049	2,242 New	2,242 $318,000
Q4 2018 Feb 14, 2019	SELL	$105.09 - $137.23 $167,933 - $219,293	-1,598 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$112.11 - $134.54 $125,002 - $150,012	1,115 Added 230.85%	1,598 $215,000
Q2 2018 Aug 14, 2018	BUY	$102.37 - $117.25 $49,444 - $56,631	483 New	483 $54,000

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.2B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Charles River Laboratories International, Inc. Transaction History